Market Cap 703.91M
Revenue (ttm) 33.28M
Net Income (ttm) -147.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -444.08%
Debt to Equity Ratio 24.92
Volume 407,600
Avg Vol 368,918
Day's Range N/A - N/A
Shares Out 80.45M
Stochastic %K 64%
Beta 1.34
Analysts Strong Sell
Price Target $23.83

Company Profile

MeiraGTx Holdings plc, a clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia. It is also developing AAV-AQP1 in Phase 2 trial for radiation-induced grade 2/3 radiation-induced xerostomia, as well as in Phase ½ trial for Sjogren's syndrome; AAV-GAD in Phase 2...

Industry: Biotechnology
Sector: Healthcare
Phone: 646 860 7985
Address:
450 East 29th Street, 14th Floor, New York, United States
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 24 at 9:21 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $MGTX Current Share Price: $8.63 Contracts: $MGTX April 17, 2026 $10 Calls Scale in: $1.77- $2.16 Scale out: $2.75-$3.53 Can Easily Capture: 60% ROI Blended DTE: 176 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
ErnieWorthing84
ErnieWorthing84 Oct. 24 at 2:48 PM
$MGTX Hmm, Lilly just bought an ocular gtx focused on intravitreal delivery...
1 · Reply
Helpmrwizard
Helpmrwizard Oct. 23 at 4:39 AM
$MGTX did I hear correctly (panel webcast) that Zandy expects JNJ to file “nearish term?” If successfully approved, that’s $5/ share cash plus mfgring sales; I doubt they would file if they were not confident of approval
1 · Reply
stockanalysis_
stockanalysis_ Oct. 22 at 9:11 PM
After Hours Losers: $AZI $BENF $AIRE $MGTX $YYAI Bookmark this screener: https://stockanalysis.com/markets/afterhours/losers/?ref=saveontrading
0 · Reply
RunnerSignals
RunnerSignals Oct. 22 at 8:33 PM
Triple-digit targets on $MGTX $DCTH while $DKNG $MGM $FLUT getting love too 🎯 Upgrade szn hits different 🔥 https://stocksrunner.com/news/2025-10-22-stock-upgrades-today-worth-watching-for-active-traders
0 · Reply
BigDaddy_LongTrades
BigDaddy_LongTrades Oct. 22 at 6:27 PM
$MGTX well i took a chance and sold all on the pop because sadly Ive seen this story before w Meira... now the question is where do I rebuy at?
1 · Reply
ErnieWorthing84
ErnieWorthing84 Oct. 22 at 12:18 PM
$MGTX Use your 🧠. Don't be a 🐑💩
0 · Reply
waterlock
waterlock Oct. 22 at 5:44 AM
$MGTX What a nice day for $MGNX $MGTX
0 · Reply
rulesmoney
rulesmoney Oct. 22 at 2:49 AM
$MGTX Read the footnotes to the Form 4. The sale is NOT a one-time sale. It is part of a Rule 10b5-1 trading plan adopted by the CFO over a year ago. He sells shares every quarter. Lots of executives in lots of companies do this to keep from having all their eggs in one basket.
0 · Reply
transfercoefficient
transfercoefficient Oct. 22 at 1:31 AM
$MGTX CFO selling a few shares. Small but still annoying.
0 · Reply
Latest News on MGTX
MeiraGTx Holdings: Gaining Regulatory Focus

Mar 25, 2025, 10:50 AM EDT - 7 months ago

MeiraGTx Holdings: Gaining Regulatory Focus


MeiraGTx Holdings: Behind The Recent Rally

Dec 3, 2024, 2:18 PM EST - 11 months ago

MeiraGTx Holdings: Behind The Recent Rally


MeiraGTx to Participate in Upcoming Investor Conferences

Apr 24, 2024, 4:30 PM EDT - 1 year ago

MeiraGTx to Participate in Upcoming Investor Conferences


MeiraGTx shares jump as Sanofi invests in gene therapy

Oct 30, 2023, 8:28 AM EDT - 2 years ago

MeiraGTx shares jump as Sanofi invests in gene therapy

SNY


LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 24 at 9:21 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $MGTX Current Share Price: $8.63 Contracts: $MGTX April 17, 2026 $10 Calls Scale in: $1.77- $2.16 Scale out: $2.75-$3.53 Can Easily Capture: 60% ROI Blended DTE: 176 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
ErnieWorthing84
ErnieWorthing84 Oct. 24 at 2:48 PM
$MGTX Hmm, Lilly just bought an ocular gtx focused on intravitreal delivery...
1 · Reply
Helpmrwizard
Helpmrwizard Oct. 23 at 4:39 AM
$MGTX did I hear correctly (panel webcast) that Zandy expects JNJ to file “nearish term?” If successfully approved, that’s $5/ share cash plus mfgring sales; I doubt they would file if they were not confident of approval
1 · Reply
stockanalysis_
stockanalysis_ Oct. 22 at 9:11 PM
After Hours Losers: $AZI $BENF $AIRE $MGTX $YYAI Bookmark this screener: https://stockanalysis.com/markets/afterhours/losers/?ref=saveontrading
0 · Reply
RunnerSignals
RunnerSignals Oct. 22 at 8:33 PM
Triple-digit targets on $MGTX $DCTH while $DKNG $MGM $FLUT getting love too 🎯 Upgrade szn hits different 🔥 https://stocksrunner.com/news/2025-10-22-stock-upgrades-today-worth-watching-for-active-traders
0 · Reply
BigDaddy_LongTrades
BigDaddy_LongTrades Oct. 22 at 6:27 PM
$MGTX well i took a chance and sold all on the pop because sadly Ive seen this story before w Meira... now the question is where do I rebuy at?
1 · Reply
ErnieWorthing84
ErnieWorthing84 Oct. 22 at 12:18 PM
$MGTX Use your 🧠. Don't be a 🐑💩
0 · Reply
waterlock
waterlock Oct. 22 at 5:44 AM
$MGTX What a nice day for $MGNX $MGTX
0 · Reply
rulesmoney
rulesmoney Oct. 22 at 2:49 AM
$MGTX Read the footnotes to the Form 4. The sale is NOT a one-time sale. It is part of a Rule 10b5-1 trading plan adopted by the CFO over a year ago. He sells shares every quarter. Lots of executives in lots of companies do this to keep from having all their eggs in one basket.
0 · Reply
transfercoefficient
transfercoefficient Oct. 22 at 1:31 AM
$MGTX CFO selling a few shares. Small but still annoying.
0 · Reply
Doozio
Doozio Oct. 21 at 6:18 PM
$MGTX 🐒🍌🧠⏰♾️
0 · Reply
DARKP00L
DARKP00L Oct. 21 at 5:43 PM
$MGTX 13:40 on Oct. 21 2025 Raymond James Initiates Coverage On MeiraGTx Hldgs with Strong Buy Rating, Announces Price Target of $29 #tradeideas
0 · Reply
JarvisFlow
JarvisFlow Oct. 21 at 5:40 PM
Raymond James has adjusted their stance on MeiraGTx Hldgs ( $MGTX ), setting the rating to Strong Buy with a target price of 29.
0 · Reply
stockpicker63
stockpicker63 Oct. 21 at 3:24 PM
$MGTX Now +5.7%
0 · Reply
ErnieWorthing84
ErnieWorthing84 Oct. 21 at 3:18 PM
0 · Reply
stockpicker63
stockpicker63 Oct. 21 at 2:26 PM
$MGTX appears to be in a favourable technical posture for a potential breakout, given its consolidation, support/resistance structure, and positive momentum signals. It’s on the radar.
0 · Reply
ErnieWorthing84
ErnieWorthing84 Oct. 21 at 1:44 PM
$MGTX Expect XLRP "to be filed in the near-ish term"
1 · Reply
vu_jade
vu_jade Oct. 20 at 10:56 PM
$MGTX bullish look
0 · Reply
notreload_ai
notreload_ai Oct. 20 at 9:04 PM
Raymond James initiates $MGTX with Strong Buy rating and $29 price target, highlighting company's manufacturing platform and two major commercial opportunities in xerostomia and Parkinson's disease. https://notreload.xyz/raymond-james-initiates-meiragtx-strong-buy-rating/
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 20 at 7:46 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $MGTX Current Share Price: $7.75 Contracts: $MGTX April 17, 2026 $10 Calls Scale in: $0.75- $0.92 Scale out: $1.17-$1.51 Can Easily Capture: 60% ROI Blended DTE: 180 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
ErnieWorthing84
ErnieWorthing84 Oct. 20 at 6:35 PM
$MGTX https://www.linkedin.com/posts/genetherapy-biotech-innovation-share-7386098097644498944-buZw?utm_source=share&utm_medium=member_desktop&rcm=ACoAAFicp8EBCpjqvJoEMU3md0X2SKAJxYKoJms
1 · Reply
slinghook67
slinghook67 Oct. 19 at 2:55 PM
$MGTX Here’s something that I found very interesting. Elemer Piros (Ph. D and Managing Director, Healthcare Equity Research @ Lucid Capital Management), was rated in separate years by the Wall Street Journal and the Financial Times as the #1 Biotech analyst based on stock portfolio performance. He also has a Ph. D from UCLA in Neuroscience. I share all of this because his current price target on MeiraGTx is $50.
2 · Reply